Mandate

Vinge advises PPR S.A in connection with the sale of Ellos and Jotex

February 25, 2013

Vinge has advised PPR S.A in connection with the sale of Ellos and Jotex to Nordic Capital Fund VII for an enterprise value of €275 million. Ellos is the leading home shopping player in Scandinavia for apparel and Jotex has established itself as a key player in the Scandinavian home textile and decoration market.

PPR S.A is one of the world’s leading apparel and accessories groups that operates in the two fastest growing market segments: Luxury and Sport & Lifestyle. The PPR Group has built a balanced collection of complementary consumer brands, including for example Gucci, Bottega Veneta, Saint Laurent, Alexander McQueen, Stella McCartney, Sergio Rossi, Girard-Perregaux, Puma and Tretorn. Present in more than 120 countries, the PPR Group generated revenues of €9.7 billion in 2012 and had over 33,000 employees at year end. The PPR share is listed on Euronext Paris.

The transaction is subject to approval of relevant competition authorities.

Vinge’s team consisted of responsible partner Johan Winnerblad together with, among others, Christina Kokko (partner) and associates Joacim Rydergård, Alex Miler, Eric Ödling, Karl Hahtovirta and project assistant Annika Johnson.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025